Search results
Do These 3 Checks Before Buying Pfizer Inc. (NYSE:PFE) For Its Upcoming Dividend
Simply Wall St. via Yahoo Finance· 2 days agoReaders hoping to buy Pfizer Inc. (NYSE:PFE) for its dividend will need to make their move shortly,...
Pfizer Inc (PFE) Q1 2024 Earnings: Adjusted EPS Surpasses Expectations Amidst Revenue Decline
GuruFocus.com via Yahoo Finance· 4 days agoFull-Year Guidance: Adjusted EPS guidance raised to $2.15 to $2.35, reaffirms revenue guidance of...
Pfizer earnings beat by $0.29, revenue topped estimates By Investing.com
Investing.com· 5 days agoPfizer earnings beat by $0.29, revenue topped estimates
FY2025 EPS Estimates for Pfizer Inc. Increased by Leerink Partnrs (NYSE:PFE)
ETF DAILY NEWS· 23 hours agoPfizer Inc. (NYSE:PFE – Free Report) – Equities research analysts at Leerink Partnrs boosted their FY2025 EPS estimates for shares of Pfizer in a research ...
Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Motley Fool via Yahoo Finance· 2 days agoBoth stocks have skyrocketed thanks largely to their obesity drugs, with Lilly's share price more...
Morgan Stanley Raises Pfizer (NYSE:PFE) Price Target to $29.00
ETF DAILY NEWS· 17 hours agoPfizer (NYSE:PFE – Free Report) had its price target boosted by Morgan Stanley from $28.00 to $29.00 in a research report report published on Thursday, Benzinga reports. They ...
Earnings call: Pfizer raises 2024 EPS outlook despite revenue decline By Investing.com
Investing.com· 4 days agoPfizer Inc. (NYSE:PFE) reported its first-quarter financial results for 2024, indicating a solid...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 6 days agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
Zacks· 5 days agoPfizer (PFE) beats first-quarter estimates for earnings and sales. It raises 2024 earnings guidance while retaining revenue expectations.
3 No-Brainer Stocks to Buy in May
Motley Fool via Yahoo Finance· 15 hours agoThree Motley Fool contributors have identified stocks they think are no-brainers to buy in May. Here's why they picked Eli Lilly (NYSE: LLY), Pfizer...